Position in ALNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$98,737
+$2,785 QoQ
Shares Held
328
+13.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#612
of 784 holders
Holding Since
Dec 2022
8 quarters on record
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Park Place Capital Corp holds $841,864 across 23 Biotechnology names. ALNY ranks #3 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
676 | $335,789 | |
| 2 | RPRX |
Royalty Pharma plc
|
3,510 | $196,805 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
328 | $98,737 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
1,433 | $81,996 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
594 | $46,492 | |
| 6 | TECH |
BIO-TECHNE Corp
|
468 | $33,064 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
94 | $22,651 | |
| 8 | ARGX |
Argenx SE
|
6 | $5,566 |
All Filings in ALNY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $98,737 | 328 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $95,952 | 290 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $50,103 | 126 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $57,456 | 126 | Shares | Sole | 2025-10-22 | |
| 2023-09-30 | $8,677 | 49 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $9,307 | 49 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $9,815 | 49 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $14,021 | 59 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||